| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY |
|---|---|---|---|---|
| Revenue | $23.60M | $21.50M | $24.44M | $23.44M |
| Cost of Revenue | $7.64M | $11.07M | $15.21M | $14.68M |
| Gross Profit | $15.96M | $10.43M | $9.23M | $8.76M |
| Operating Expenses | $21.20M | $24.23M | $16.91M | $17.38M |
| R&D | – | – | – | – |
| SG&A | $17.96M | $20.68M | $12.12M | $12.37M |
| Operating Income | -$5.24M | -$13.80M | -$7.67M | -$8.63M |
| Interest Expense | – | – | $1.31M | $1.84M |
| Tax Expense | – | – | – | -$121.00K |
| Net Income | -$7.13M | -$15.94M | -$8.72M | -$10.30M |
| EPS (basic) | -0.2300 | -0.9900 | -1.3400 | -2.1600 |
| EPS (diluted) | -0.2300 | -0.9900 | -1.3400 | -2.1600 |
| Shares (diluted) | $33.07M | $16.10M | $6.52M | $4.77M |